ACTG 254--ATOVAQUONE/AZITHROMYCIN VS TMP/SMX TO PREVENT BACTERIAL INFECTION

ACTG 254--阿托伐醌/阿奇霉素与 TMP/SMX 预防细菌感染

• 批准号: 6276200
• 负责人: ELIZABETH G MCFARLAND
• 金额: $ 1.86万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6276200
• 关键词: Pneumocystis pneumonia; atovaquone; azithromycin; bacterial disease; chemoprevention; child (0-11); clinical research; human subject; human therapy evaluation; microorganism disease chemotherapy; sulfamethoxazole; trimethoprim

This study will compare the safety, tolerance and efficacy of the combination of atovaquone and azithromycin to trimethoprim- sulfamethoxazole in the prevention of serious bacterial infections and the prophylaxis of PCP.

本研究将比较 阿托伐醌和阿奇霉素的组合与甲氧苄啶- 磺胺甲恶唑在预防严重细菌感染和 预防PCP。